News stories about Flamel Technologies (NASDAQ:AVDL) have trended somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Flamel Technologies earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.5327958490973 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
AVDL has been the topic of several research reports. Zacks Investment Research upgraded shares of Flamel Technologies from a “hold” rating to a “buy” rating and set a $12.00 price target on the stock in a report on Monday, July 17th. Roth Capital set a $15.00 price target on shares of Flamel Technologies and gave the company a “buy” rating in a report on Wednesday, August 9th. Ladenburg Thalmann Financial Services raised their price target on shares of Flamel Technologies from $27.00 to $30.00 in a report on Thursday, September 7th. Finally, Langenberg & Company restated a “buy” rating and issued a $30.00 price target (up previously from $27.00) on shares of Flamel Technologies in a report on Thursday, September 7th. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $19.83.
Flamel Technologies (AVDL) traded up 0.10% on Friday, reaching $9.61. 199,950 shares of the company traded hands. Flamel Technologies has a 52-week low of $8.14 and a 52-week high of $13.89. The firm has a 50 day moving average price of $9.01 and a 200 day moving average price of $9.80. The stock has a market capitalization of $385.21 million, a price-to-earnings ratio of 10.15 and a beta of 1.39.
Flamel Technologies (NASDAQ:AVDL) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.05 by $0.14. The business had revenue of $46.30 million during the quarter, compared to analyst estimates of $45.17 million. Flamel Technologies had a return on equity of 29.84% and a net margin of 21.13%. Flamel Technologies’s quarterly revenue was up 19.0% on a year-over-year basis. Equities research analysts predict that Flamel Technologies will post $1.16 EPS for the current year.
In other news, Director Craig R. Stapleton purchased 20,000 shares of Flamel Technologies stock in a transaction dated Tuesday, September 12th. The stock was acquired at an average cost of $9.52 per share, for a total transaction of $190,400.00. Following the acquisition, the director now directly owns 507,678 shares in the company, valued at $4,833,094.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Greg J. Divis purchased 10,600 shares of Flamel Technologies stock in a transaction dated Tuesday, September 12th. The shares were purchased at an average price of $9.32 per share, with a total value of $98,792.00. Following the completion of the acquisition, the insider now owns 10,600 shares in the company, valued at $98,792. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 41,700 shares of company stock valued at $394,848. 5.07% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: “Flamel Technologies (AVDL) Earning Somewhat Positive Press Coverage, Study Shows” was first published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://transcriptdaily.com/2017/09/24/flamel-technologies-avdl-earning-somewhat-positive-press-coverage-study-shows.html.
Flamel Technologies Company Profile
Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.
Receive News & Ratings for Flamel Technologies S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flamel Technologies S.A. and related companies with MarketBeat.com's FREE daily email newsletter.